Testing a generic malaria medicine in healthy volunteers
Part of Infections clinical trials.
This study tests a generic version of a malaria medicine (sulfadoxine/pyrimethamine) to see if it works the same as the original. Healthy volunteers take a single dose and have their blood checked over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 50 years old (or a post-menopausal woman age 45 to 65).
- Have a body mass index (BMI) between 18.5 and 30.0.
- Be generally healthy with no major medical problems, and no history of drug or alcohol abuse.
- Not be allergic to sulfadoxine, pyrimethamine, or similar medicines.
- Be willing to avoid certain foods and drinks (alcohol, caffeine, grapefruit) and all other medications for a specific period before and during the study.
- Not have taken part in another clinical trial within the last 90 days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of three malaria medicines in healthy volunteers to see how safe they are and how the body processes them. If you are a healthy non-smoker, you may be able to help researchers understand these drugs better.
This study tests a new experimental antimalarial drug (GSK3772701) to see if it can safely and effectively treat uncomplicated malaria caused by P. falciparum parasites. You would receive the study drug by mouth and be monitored closely with blood tests and heart rhythm checks.
This is an early-stage safety study testing a new experimental drug (GSK4425689A) in healthy volunteers. Researchers want to find safe doses and understand how the body processes this medication.
This trial tests a new malaria drug (MMV055), alone or with another drug (MMV371), to see if it is safe and how the body processes it. It is for healthy people who want to help find new malaria treatments.
This Phase 1 study tests how safe a combination oral medicine (ZY19489 with ferroquine) is in adults who carry malaria in their blood but have no symptoms. It also studies how the body absorbs and processes the medicines.
This trial uses a genetically modified malaria parasite given by mosquito bite to safely test a new vaccine approach in healthy volunteers. If you qualify, you'll help researchers understand how the body defends against malaria.
Hear when a new Fasting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.